Latest Breaking News On - ஜாகோப் கோல்ட்பர்கர் - Page 1 : comparemela.com

PDS Biotech Announces Presentation and Panel Participation at the Benzinga Biotech Small Cap Conference Florham Park, New Jersey (Newsfile Corp. - March 17, 2021) - PDS Biotechnology Corporation (NASDAQ: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company s proprietary Versamune® T-cell activating technology, today announced that Dr. Frank Bedu-Addo, CEO of PDS Biotech, will present the company s immunotherapy platform, ongoing phase 2 clinical programs, product pipeline and upcoming milestones virtually at the Benzinga Biotech Small Cap Conference on Wednesday, March 24 at 10:05 am ET. In addition, Dr. Bedu-Addo will participate in the Cancer Immunotherapies: Fighting Cancer with the power of the Immune System panel immediately following his presentation at 10:25am ET on Wednesday, March 24.

Jacob goldbergerFrank beduDeanne randolphJersey newsfile corpBiotechnology corporationFlorham parkFrank bedu addoBenzinga biotech small cap conferenceFighting cancerInvestor relations contactஜாகோப் கோல்ட்பர்கர்வெளிப்படையான பேடுடீன் ரேண்டால்ஃப்உயிரி தொழில்நுட்பவியல் நிறுவனம்புளோர்ஹாம் பூங்காவெளிப்படையான பேடு